13-110480209-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001846.4(COL4A2):​c.2588-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.301 in 1,581,508 control chromosomes in the GnomAD database, including 74,393 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6061 hom., cov: 34)
Exomes 𝑓: 0.31 ( 68332 hom. )

Consequence

COL4A2
NM_001846.4 intron

Scores

2
Splicing: ADA: 0.00004166
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.08
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 13-110480209-C-T is Benign according to our data. Variant chr13-110480209-C-T is described in ClinVar as [Benign]. Clinvar id is 311151.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-110480209-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A2NM_001846.4 linkc.2588-11C>T intron_variant Intron 30 of 47 ENST00000360467.7 NP_001837.2 P08572A0A024RDW8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkc.2588-11C>T intron_variant Intron 30 of 47 5 NM_001846.4 ENSP00000353654.5 P08572
COL4A2ENST00000483683.2 linkn.218-11C>T intron_variant Intron 1 of 2 2
COL4A2ENST00000650225.1 linkn.243-11C>T intron_variant Intron 1 of 18

Frequencies

GnomAD3 genomes
AF:
0.260
AC:
39575
AN:
152078
Hom.:
6053
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0852
Gnomad AMI
AF:
0.295
Gnomad AMR
AF:
0.350
Gnomad ASJ
AF:
0.311
Gnomad EAS
AF:
0.337
Gnomad SAS
AF:
0.281
Gnomad FIN
AF:
0.390
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.284
GnomAD3 exomes
AF:
0.308
AC:
68886
AN:
223460
Hom.:
11116
AF XY:
0.309
AC XY:
37659
AN XY:
121756
show subpopulations
Gnomad AFR exome
AF:
0.0781
Gnomad AMR exome
AF:
0.371
Gnomad ASJ exome
AF:
0.314
Gnomad EAS exome
AF:
0.323
Gnomad SAS exome
AF:
0.282
Gnomad FIN exome
AF:
0.384
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.317
GnomAD4 exome
AF:
0.306
AC:
436893
AN:
1429312
Hom.:
68332
Cov.:
33
AF XY:
0.305
AC XY:
216954
AN XY:
710270
show subpopulations
Gnomad4 AFR exome
AF:
0.0683
Gnomad4 AMR exome
AF:
0.371
Gnomad4 ASJ exome
AF:
0.315
Gnomad4 EAS exome
AF:
0.377
Gnomad4 SAS exome
AF:
0.290
Gnomad4 FIN exome
AF:
0.381
Gnomad4 NFE exome
AF:
0.306
Gnomad4 OTH exome
AF:
0.290
GnomAD4 genome
AF:
0.260
AC:
39589
AN:
152196
Hom.:
6061
Cov.:
34
AF XY:
0.266
AC XY:
19804
AN XY:
74392
show subpopulations
Gnomad4 AFR
AF:
0.0850
Gnomad4 AMR
AF:
0.351
Gnomad4 ASJ
AF:
0.311
Gnomad4 EAS
AF:
0.337
Gnomad4 SAS
AF:
0.281
Gnomad4 FIN
AF:
0.390
Gnomad4 NFE
AF:
0.315
Gnomad4 OTH
AF:
0.282
Alfa
AF:
0.301
Hom.:
11758
Bravo
AF:
0.247
Asia WGS
AF:
0.295
AC:
1024
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Apr 02, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Porencephaly 2 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.6
DANN
Benign
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000042
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9521803; hg19: chr13-111132556; COSMIC: COSV64626324; API